Zoetis (ZTS) Capital Expenditures (2012 - 2026)
Zoetis (ZTS) reported Capital Expenditures of $110.0 million for Q1 2026, up 3566.67% year-over-year from $3.0 million in Q1 2025, and up 124.12% quarter-over-quarter from -$456.0 million in Q4 2025.
Zoetis (ZTS) Capital Expenditures (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Capital Expenditures data on file, last reported at $110.0 million in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $110.0 million, up 3566.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $111.0 million (up 182.84% YoY), and the FY2025 annual result was $4.0 million, up 33.33% from the prior year.
- Capital Expenditures rose to $110.0 million in Q1 2026 per ZTS's latest filing, from -$456.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $457.0 million in Q3 2025 and troughed at -$456.0 million in Q4 2025.
- A 5-year average of $7.6 million and a median of $3.0 million in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures soared 4566.67% in 2024, then slumped 45500.0% in 2025.
- A 5-year view of Capital Expenditures shows it stood at -$2.0 million in 2022, then changed by 0.0% to -$2.0 million in 2023, then soared by 50.0% to -$1.0 million in 2024, then tumbled by 45500.0% to -$456.0 million in 2025, then jumped by 124.12% to $110.0 million in 2026.
- Business Quant data shows ZTS's Capital Expenditures at $110.0 million in Q1 2026, -$456.0 million in Q4 2025, and $457.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 6.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.00 Mn |
| Mar 31, 2026 | 110.00 Mn |
| Dec 31, 2025 | -456.00 Mn |
| Dec 31, 2025 | -456.00 Mn |
| Sep 30, 2025 | 457.00 Mn |
| Sep 30, 2025 | 457.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -268.00 Mn |
| Sep 30, 2024 | -268.00 Mn |
| Jun 30, 2024 | 132.00 Mn |
| Jun 30, 2024 | 132.00 Mn |
| Mar 31, 2024 | 140.00 Mn |
| Mar 31, 2024 | 140.00 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Sep 30, 2023 | -385.00 Mn |
| Sep 30, 2023 | -385.00 Mn |